IL118626A0 - Anti HBV antibody - Google Patents

Anti HBV antibody

Info

Publication number
IL118626A0
IL118626A0 IL11862696A IL11862696A IL118626A0 IL 118626 A0 IL118626 A0 IL 118626A0 IL 11862696 A IL11862696 A IL 11862696A IL 11862696 A IL11862696 A IL 11862696A IL 118626 A0 IL118626 A0 IL 118626A0
Authority
IL
Israel
Prior art keywords
antibodies
hbvsag
disclosed
cell line
human
Prior art date
Application number
IL11862696A
Other languages
English (en)
Original Assignee
Xtl Biopharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xtl Biopharmaceuticals Limited filed Critical Xtl Biopharmaceuticals Limited
Priority to IL11862696A priority Critical patent/IL118626A0/xx
Publication of IL118626A0 publication Critical patent/IL118626A0/xx
Priority to IL12302597A priority patent/IL123025A0/xx
Priority to CA002227548A priority patent/CA2227548C/en
Priority to US09/000,088 priority patent/US6146629A/en
Priority to AU30454/97A priority patent/AU3045497A/en
Priority to DE69721713T priority patent/DE69721713T2/de
Priority to JP50140698A priority patent/JP3574664B2/ja
Priority to PCT/IL1997/000183 priority patent/WO1997047653A1/en
Priority to US10/465,633 priority patent/USRE39586E1/en
Priority to ES97925252T priority patent/ES2197345T3/es
Priority to DK97925252T priority patent/DK0853633T3/da
Priority to PT97925252T priority patent/PT853633E/pt
Priority to EP97925252A priority patent/EP0853633B1/de
Priority to AT97925252T priority patent/ATE239756T1/de
Priority to IL123025A priority patent/IL123025A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11862696A 1996-06-11 1996-06-11 Anti HBV antibody IL118626A0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IL11862696A IL118626A0 (en) 1996-06-11 1996-06-11 Anti HBV antibody
AT97925252T ATE239756T1 (de) 1996-06-11 1997-06-10 Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
JP50140698A JP3574664B2 (ja) 1996-06-11 1997-06-10 抗ｈｂｖ抗体
US10/465,633 USRE39586E1 (en) 1996-06-11 1997-06-10 Human monoclonal antibody against Hepatitis B virus surface antigen (HBVSAG)
US09/000,088 US6146629A (en) 1996-06-11 1997-06-10 Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)
AU30454/97A AU3045497A (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
DE69721713T DE69721713T2 (de) 1996-06-11 1997-06-10 Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
IL12302597A IL123025A0 (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (HBVSAG)
PCT/IL1997/000183 WO1997047653A1 (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
CA002227548A CA2227548C (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
ES97925252T ES2197345T3 (es) 1996-06-11 1997-06-10 Anticuerpos monoclonales humanos contra el antigeno de superficie del virus de la hepatitis b2 (hbvsag).
DK97925252T DK0853633T3 (da) 1996-06-11 1997-06-10 Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg)
PT97925252T PT853633E (pt) 1996-06-11 1997-06-10 Anticorpo monoclonal humano contra o antigenio da superficie do virus da hepatite b (agsvhb)
EP97925252A EP0853633B1 (de) 1996-06-11 1997-06-10 Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
IL123025A IL123025A (en) 1996-06-11 1998-01-22 Human monoclonal antibody against surface antigen of hepatitis B virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11862696A IL118626A0 (en) 1996-06-11 1996-06-11 Anti HBV antibody

Publications (1)

Publication Number Publication Date
IL118626A0 true IL118626A0 (en) 1996-10-16

Family

ID=11068956

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11862696A IL118626A0 (en) 1996-06-11 1996-06-11 Anti HBV antibody
IL12302597A IL123025A0 (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (HBVSAG)
IL123025A IL123025A (en) 1996-06-11 1998-01-22 Human monoclonal antibody against surface antigen of hepatitis B virus

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL12302597A IL123025A0 (en) 1996-06-11 1997-06-10 Human monoclonal antibody against hepatitis b virus surface antigen (HBVSAG)
IL123025A IL123025A (en) 1996-06-11 1998-01-22 Human monoclonal antibody against surface antigen of hepatitis B virus

Country Status (12)

Country Link
US (2) US6146629A (de)
EP (1) EP0853633B1 (de)
JP (1) JP3574664B2 (de)
AT (1) ATE239756T1 (de)
AU (1) AU3045497A (de)
CA (1) CA2227548C (de)
DE (1) DE69721713T2 (de)
DK (1) DK0853633T3 (de)
ES (1) ES2197345T3 (de)
IL (3) IL118626A0 (de)
PT (1) PT853633E (de)
WO (1) WO1997047653A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180284A1 (en) * 1998-11-05 2003-09-25 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
DE19939653A1 (de) * 1999-08-13 2001-02-22 Thomas Huenig Verwendung CD28 spezifischer monoklonaler Antikörper zur Herstellung einer pharmazeutischen Zusammensetzung
KR100419555B1 (ko) * 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
BRPI0116728B1 (pt) 2001-01-05 2018-10-30 Abgenix Inc anticorpos para receptor de fator de crescimento i semelhante à insulina
CA2441228A1 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
CA2450898A1 (en) * 2001-07-09 2003-01-23 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
SG153666A1 (en) * 2001-10-04 2009-07-29 Yeda Res & Dev Treatment of hepatitis b virus infection with human monoclonal antibodies
IL161138A0 (en) * 2001-10-04 2004-08-31 Xtl Biopharmaceuticals Ltd Treatment of hepatitis b virus infection with human monoclonal antibodies
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
KR100467706B1 (ko) * 2002-01-15 2005-01-24 주식회사 녹십자홀딩스 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체
FR2844455B1 (fr) * 2002-09-13 2007-12-14 Lab Francais Du Fractionnement Traitement des pathologies echappant a la reponse immune par des anticorps optimises
WO2004071529A2 (en) * 2003-02-13 2004-08-26 Pfizer Products Inc. Uses of anti-insulin-like growth factor i receptor antibodies
JP4638870B2 (ja) * 2003-08-13 2011-02-23 ファイザー・プロダクツ・インク 修飾ヒトｉｇｆ−１ｒ抗体
EP2322217A3 (de) * 2004-07-16 2011-09-28 Pfizer Products Inc. Kombinationsbehandlung für nicht-hämatologische bösartige Erkrankungen mit einem anti-IGF-1R-Antikörper
KR20070053229A (ko) * 2004-08-13 2007-05-23 미게닉스 인코포레이티드 헤파드나비리대 감염을 치료 또는 예방하기 위한 조성물 및방법
CA2580965C (en) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Monoclonal antibodies to progastrin
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
KR101280273B1 (ko) 2005-04-18 2013-07-15 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 안정화된 항-ｂ형 간염 바이러스 (ｈｂｖ) 항체 제형
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US20100150942A1 (en) * 2008-12-03 2010-06-17 Cantor Thomas L Affinity purified human polyclonal antibodies and methods of making and using them
KR20150070181A (ko) 2012-09-27 2015-06-24 크루셀 홀란드 비.브이. B형 간염 바이러스에 결합하고 이를 중화시킬 수 있는 인간 결합 분자 및 그의 용도
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
EP3801766A1 (de) * 2018-05-31 2021-04-14 Novartis AG Hepatitis-b-antikörper
US20230265168A1 (en) * 2020-07-09 2023-08-24 Beijing Kawin Technology Share-Holding Co., Ltd. Antibody binding to hepatitis b virus surface antigen and application of antibody
CN114671947B (zh) * 2022-02-28 2024-04-09 中国科学院生物物理研究所 乙肝病毒不同亚型表面s蛋白高亲和力纳米抗体及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
US4714613A (en) * 1982-09-30 1987-12-22 The Albert Einstein College Of Medicine Of Yeshiva University Method of suppressing cell growth by immunotherapy
US4624918A (en) 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
JPS61104796A (ja) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体の製造方法
JPS61179483A (ja) * 1985-02-04 1986-08-12 Sharp Corp 感光体疲労防止装置
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US5565354A (en) * 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
EP0468119A1 (de) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Neue Carbocyclische Analoge einiger Nukleoside
GB9202796D0 (en) * 1992-02-11 1992-03-25 Wellcome Found Antiviral antibody
WO1994011495A1 (en) * 1992-11-06 1994-05-26 Sandoz, Ltd. Production of human monoclonal antibodies active against hepatitis b surface antigen
WO1994026784A1 (en) * 1993-05-10 1994-11-24 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Composition of antibodies against hepatitis b surface antigen
GB9608626D0 (en) 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
IL118625A0 (en) 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibodies

Also Published As

Publication number Publication date
USRE39586E1 (en) 2007-04-24
DK0853633T3 (da) 2003-08-04
DE69721713D1 (de) 2003-06-12
IL123025A (en) 2006-09-05
PT853633E (pt) 2003-09-30
CA2227548C (en) 2004-07-20
ATE239756T1 (de) 2003-05-15
DE69721713T2 (de) 2004-03-11
WO1997047653A1 (en) 1997-12-18
EP0853633B1 (de) 2003-05-07
AU3045497A (en) 1998-01-07
JP3574664B2 (ja) 2004-10-06
CA2227548A1 (en) 1997-12-18
EP0853633A1 (de) 1998-07-22
IL123025A0 (en) 1998-09-24
JP2000506741A (ja) 2000-06-06
ES2197345T3 (es) 2004-01-01
US6146629A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
IL118626A0 (en) Anti HBV antibody
PT912611E (pt) Anticorpos monoclonais humanos para o anti-gene de superficie da hepatite b
ES2173237T3 (es) Procedimiento de fabricacion de anticuerpos monoclonales humanos y su uso.
DK0752869T3 (da) Celler med talrige ændrede epitoper på et overfladeantigen til anvendelse ved transplantationen
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
KR890701771A (ko) Hiv 항원에 특이적인 단일 클론 항체
FI931393A0 (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
DE3584872D1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
AU8242501A (en) Human monoclonal antibody against hepatitis c virus e2 glycoprotein
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
CA2101534A1 (en) Monoclonal antibodies to putative hcv envelope region and methods for using same
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
CA2254931A1 (en) Human monoclonal antibodies to the hepatitis b surface antigen
CA2112667A1 (en) Monoclonal antibodies to putative hcv ns5 proteins and methods for using same
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
EP0089771A3 (de) ATCC HB 8116 und sein monoklonaler anti-h-y Antikörper, hyklonalan
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
Kulikov et al. Immunization of human lymphocytes with Epstein-Barr virus capsid antigens in vitro
BG51639A1 (en) Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody towards antigenous determinant of strain " hantaan " of the virus of haemorrhagic fever with nephritic syndrome
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
NZ337056A (en) A 24 kD protein specific for binding to HCV epitotes which can be used for diagnosis and treatment of HCV related diseases